nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Carmustine—brain cancer	0.178	0.351	CbGbCtD
Rifabutin—CYP3A4—Temozolomide—brain cancer	0.134	0.265	CbGbCtD
Rifabutin—CYP3A4—Lomustine—brain cancer	0.114	0.225	CbGbCtD
Rifabutin—CYP1A2—Etoposide—brain cancer	0.0527	0.104	CbGbCtD
Rifabutin—CYP3A4—Etoposide—brain cancer	0.0276	0.0545	CbGbCtD
Rifabutin—HSP90AA1—pons—brain cancer	0.0218	0.122	CbGeAlD
Rifabutin—HSP90AA1—pineal body—brain cancer	0.0156	0.0869	CbGeAlD
Rifabutin—HSP90B1—hindbrain—brain cancer	0.0116	0.0647	CbGeAlD
Rifabutin—HSP90AA1—ganglion—brain cancer	0.0112	0.0624	CbGeAlD
Rifabutin—HSP90AA1—endothelium—brain cancer	0.00964	0.0538	CbGeAlD
Rifabutin—HSP90AA1—blood vessel—brain cancer	0.00889	0.0496	CbGeAlD
Rifabutin—HSP90AA1—hindbrain—brain cancer	0.00848	0.0473	CbGeAlD
Rifabutin—HSP90B1—brainstem—brain cancer	0.00664	0.0371	CbGeAlD
Rifabutin—HSP90B1—telencephalon—brain cancer	0.00589	0.0329	CbGeAlD
Rifabutin—Emotional distress—Hydroxyurea—brain cancer	0.00523	0.0327	CcSEcCtD
Rifabutin—HSP90B1—gonad—brain cancer	0.00492	0.0275	CbGeAlD
Rifabutin—HSP90AA1—brainstem—brain cancer	0.00486	0.0271	CbGeAlD
Rifabutin—Rifapentine—CYP2C9—brain cancer	0.00481	0.616	CrCbGaD
Rifabutin—HSP90B1—pituitary gland—brain cancer	0.0048	0.0268	CbGeAlD
Rifabutin—HSP90B1—medulla oblongata—brain cancer	0.00463	0.0259	CbGeAlD
Rifabutin—HSP90AA1—telencephalon—brain cancer	0.00431	0.0241	CbGeAlD
Rifabutin—HSP90B1—midbrain—brain cancer	0.00423	0.0236	CbGeAlD
Rifabutin—HSP90B1—spinal cord—brain cancer	0.00413	0.0231	CbGeAlD
Rifabutin—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00378	0.0236	CcSEcCtD
Rifabutin—Platelet count decreased—Hydroxyurea—brain cancer	0.00374	0.0233	CcSEcCtD
Rifabutin—HSP90B1—endocrine gland—brain cancer	0.00372	0.0208	CbGeAlD
Rifabutin—HSP90B1—head—brain cancer	0.00367	0.0205	CbGeAlD
Rifabutin—HSP90AA1—gonad—brain cancer	0.0036	0.0201	CbGeAlD
Rifabutin—HSP90AA1—pituitary gland—brain cancer	0.00351	0.0196	CbGeAlD
Rifabutin—Lymphopenia—Temozolomide—brain cancer	0.00339	0.0212	CcSEcCtD
Rifabutin—HSP90AA1—medulla oblongata—brain cancer	0.00339	0.0189	CbGeAlD
Rifabutin—HSP90B1—central nervous system—brain cancer	0.00335	0.0187	CbGeAlD
Rifabutin—HSP90B1—cerebellum—brain cancer	0.00327	0.0183	CbGeAlD
Rifabutin—HSP90AA1—midbrain—brain cancer	0.0031	0.0173	CbGeAlD
Rifabutin—HSP90AA1—spinal cord—brain cancer	0.00302	0.0169	CbGeAlD
Rifabutin—Rifampicin—CYP2C9—brain cancer	0.003	0.384	CrCbGaD
Rifabutin—Aphasia—Carmustine—brain cancer	0.00277	0.0173	CcSEcCtD
Rifabutin—HSP90AA1—endocrine gland—brain cancer	0.00272	0.0152	CbGeAlD
Rifabutin—Pancytopenia—Lomustine—brain cancer	0.0027	0.0168	CcSEcCtD
Rifabutin—HSP90AA1—head—brain cancer	0.00268	0.015	CbGeAlD
Rifabutin—Aphasia—Temozolomide—brain cancer	0.00268	0.0167	CcSEcCtD
Rifabutin—HSP90B1—brain—brain cancer	0.00266	0.0148	CbGeAlD
Rifabutin—HSP90AA1—G2/M Transition—PPP1R12A—brain cancer	0.00254	0.0173	CbGpPWpGaD
Rifabutin—HSP90AA1—Mitotic G2-G2/M phases—PPP1R12A—brain cancer	0.0025	0.0171	CbGpPWpGaD
Rifabutin—HSP90AA1—central nervous system—brain cancer	0.00245	0.0137	CbGeAlD
Rifabutin—HSP90AA1—cerebellum—brain cancer	0.00239	0.0134	CbGeAlD
Rifabutin—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00235	0.0147	CcSEcCtD
Rifabutin—HSP90AA1—ErbB receptor signaling network—ERBB2—brain cancer	0.00218	0.0149	CbGpPWpGaD
Rifabutin—HSP90AA1—brain—brain cancer	0.00195	0.0109	CbGeAlD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.00192	0.0131	CbGpPWpGaD
Rifabutin—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—CDKN2A—brain cancer	0.00188	0.0129	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular response to heat stress—SIRT1—brain cancer	0.00187	0.0128	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—EHMT1—brain cancer	0.00186	0.0127	CbGpPWpGaD
Rifabutin—Hepatic enzyme increased—Temozolomide—brain cancer	0.00184	0.0115	CcSEcCtD
Rifabutin—Eosinophilia—Procarbazine—brain cancer	0.00178	0.0111	CcSEcCtD
Rifabutin—Leukopenia—Lomustine—brain cancer	0.00177	0.0111	CcSEcCtD
Rifabutin—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00177	0.0121	CbGpPWpGaD
Rifabutin—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00174	0.0108	CcSEcCtD
Rifabutin—Pancytopenia—Procarbazine—brain cancer	0.00171	0.0107	CcSEcCtD
Rifabutin—HSP90B1—IL6-mediated signaling events—STAT3—brain cancer	0.00171	0.0116	CbGpPWpGaD
Rifabutin—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.0017	0.0116	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—MYC—brain cancer	0.00158	0.0108	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Lomustine—brain cancer	0.00158	0.00987	CcSEcCtD
Rifabutin—Pain—Carboplatin—brain cancer	0.00158	0.00986	CcSEcCtD
Rifabutin—Chest discomfort—Etoposide—brain cancer	0.00157	0.00981	CcSEcCtD
Rifabutin—Jaundice—Procarbazine—brain cancer	0.00157	0.00978	CcSEcCtD
Rifabutin—HSP90AA1—EBV LMP1 signaling—RELA—brain cancer	0.00156	0.0106	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00155	0.0106	CbGpPWpGaD
Rifabutin—Anorexia—Lomustine—brain cancer	0.00154	0.00961	CcSEcCtD
Rifabutin—Skin discolouration—Etoposide—brain cancer	0.00154	0.00961	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of actin dynamics for phagocytic cup formation—VAV1—brain cancer	0.00152	0.0104	CbGpPWpGaD
Rifabutin—HSP90AA1—ErbB receptor signaling network—EGFR—brain cancer	0.00151	0.0103	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—HES1—brain cancer	0.00149	0.0102	CbGpPWpGaD
Rifabutin—Body temperature increased—Carboplatin—brain cancer	0.00146	0.00911	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00145	0.00905	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00143	0.00979	CbGpPWpGaD
Rifabutin—Decreased appetite—Lomustine—brain cancer	0.0014	0.00877	CcSEcCtD
Rifabutin—Phosphatase alkaline increased—Etoposide—brain cancer	0.00139	0.00868	CcSEcCtD
Rifabutin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00136	0.0093	CbGpPWpGaD
Rifabutin—Pancytopenia—Hydroxyurea—brain cancer	0.00132	0.00827	CcSEcCtD
Rifabutin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00131	0.00895	CbGpPWpGaD
Rifabutin—Neutropenia—Hydroxyurea—brain cancer	0.0013	0.00815	CcSEcCtD
Rifabutin—Body temperature increased—Lomustine—brain cancer	0.00128	0.00797	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by constitutively active EGFR—EGFR—brain cancer	0.00125	0.00852	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00118	0.00735	CcSEcCtD
Rifabutin—HSP90AA1—Class I PI3K signaling events—PIK3CG—brain cancer	0.00116	0.00794	CbGpPWpGaD
Rifabutin—Anaemia—Procarbazine—brain cancer	0.00116	0.00725	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00116	0.00724	CcSEcCtD
Rifabutin—HSP90AA1—VEGFR2 mediated vascular permeability—CTNNB1—brain cancer	0.00116	0.00789	CbGpPWpGaD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00116	0.00789	CbGpPWpGaD
Rifabutin—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—VAV1—brain cancer	0.00115	0.00782	CbGpPWpGaD
Rifabutin—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00114	0.00709	CcSEcCtD
Rifabutin—Leukopenia—Procarbazine—brain cancer	0.00112	0.00702	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—SPP1—brain cancer	0.00111	0.0076	CbGpPWpGaD
Rifabutin—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00111	0.00695	CcSEcCtD
Rifabutin—Convulsion—Procarbazine—brain cancer	0.00109	0.0068	CcSEcCtD
Rifabutin—Pancytopenia—Carmustine—brain cancer	0.00107	0.00669	CcSEcCtD
Rifabutin—Myalgia—Procarbazine—brain cancer	0.00107	0.00668	CcSEcCtD
Rifabutin—Arthralgia—Procarbazine—brain cancer	0.00107	0.00668	CcSEcCtD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—RELA—brain cancer	0.00106	0.00726	CbGpPWpGaD
Rifabutin—Neutropenia—Carmustine—brain cancer	0.00105	0.00659	CcSEcCtD
Rifabutin—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—brain cancer	0.00105	0.00716	CbGpPWpGaD
Rifabutin—Pancytopenia—Temozolomide—brain cancer	0.00103	0.00646	CcSEcCtD
Rifabutin—Confusional state—Procarbazine—brain cancer	0.00103	0.00645	CcSEcCtD
Rifabutin—Vomiting—Lomustine—brain cancer	0.00103	0.00641	CcSEcCtD
Rifabutin—Neutropenia—Temozolomide—brain cancer	0.00102	0.00636	CcSEcCtD
Rifabutin—Shock—Procarbazine—brain cancer	0.00101	0.0063	CcSEcCtD
Rifabutin—Thrombocytopenia—Procarbazine—brain cancer	0.001	0.00627	CcSEcCtD
Rifabutin—HSP90AA1—VEGFR1 specific signals—VEGFA—brain cancer	0.00099	0.00675	CbGpPWpGaD
Rifabutin—HSP90AA1—NOD pathway—RELA—brain cancer	0.00098	0.00669	CbGpPWpGaD
Rifabutin—Anorexia—Procarbazine—brain cancer	0.000977	0.0061	CcSEcCtD
Rifabutin—Nausea—Lomustine—brain cancer	0.000959	0.00599	CcSEcCtD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—IL2—brain cancer	0.000958	0.00654	CbGpPWpGaD
Rifabutin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000936	0.00639	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—RELA—brain cancer	0.000934	0.00638	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000934	0.00583	CcSEcCtD
Rifabutin—Insomnia—Procarbazine—brain cancer	0.000927	0.00579	CcSEcCtD
Rifabutin—Paraesthesia—Procarbazine—brain cancer	0.00092	0.00575	CcSEcCtD
Rifabutin—Hepatobiliary disease—Temozolomide—brain cancer	0.000919	0.00574	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VAV1—brain cancer	0.000917	0.00626	CbGpPWpGaD
Rifabutin—Anaemia—Hydroxyurea—brain cancer	0.000898	0.00561	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000894	0.0061	CbGpPWpGaD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000892	0.00609	CbGpPWpGaD
Rifabutin—Decreased appetite—Procarbazine—brain cancer	0.000891	0.00556	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Etoposide—brain cancer	0.00089	0.00556	CcSEcCtD
Rifabutin—Connective tissue disorder—Carmustine—brain cancer	0.000887	0.00554	CcSEcCtD
Rifabutin—CYP1A2—endocrine gland—brain cancer	0.000879	0.00491	CbGeAlD
Rifabutin—Pain—Procarbazine—brain cancer	0.000876	0.00547	CcSEcCtD
Rifabutin—Hepatitis—Temozolomide—brain cancer	0.000872	0.00545	CcSEcCtD
Rifabutin—HSP90AA1—EPHA-mediated growth cone collapse—VEGFA—brain cancer	0.000871	0.00594	CbGpPWpGaD
Rifabutin—Leukopenia—Hydroxyurea—brain cancer	0.00087	0.00543	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—VAV1—brain cancer	0.000866	0.00591	CbGpPWpGaD
Rifabutin—Bronchospasm—Etoposide—brain cancer	0.000858	0.00536	CcSEcCtD
Rifabutin—Connective tissue disorder—Temozolomide—brain cancer	0.000857	0.00535	CcSEcCtD
Rifabutin—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000849	0.00579	CbGpPWpGaD
Rifabutin—Feeling abnormal—Procarbazine—brain cancer	0.000845	0.00528	CcSEcCtD
Rifabutin—Eye disorder—Carmustine—brain cancer	0.000843	0.00527	CcSEcCtD
Rifabutin—Convulsion—Hydroxyurea—brain cancer	0.000842	0.00526	CcSEcCtD
Rifabutin—Gastrointestinal pain—Procarbazine—brain cancer	0.000838	0.00523	CcSEcCtD
Rifabutin—Pancytopenia—Etoposide—brain cancer	0.000828	0.00517	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000822	0.00513	CcSEcCtD
Rifabutin—Neutropenia—Etoposide—brain cancer	0.000815	0.00509	CcSEcCtD
Rifabutin—Eye disorder—Temozolomide—brain cancer	0.000815	0.00509	CcSEcCtD
Rifabutin—Abdominal pain—Procarbazine—brain cancer	0.00081	0.00506	CcSEcCtD
Rifabutin—Body temperature increased—Procarbazine—brain cancer	0.00081	0.00506	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000807	0.00551	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000805	0.00549	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrin-linked kinase signaling—CCND1—brain cancer	0.000799	0.00545	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrin-linked kinase signaling—CTNNB1—brain cancer	0.000791	0.0054	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—CDK4—brain cancer	0.000788	0.00538	CbGpPWpGaD
Rifabutin—Immune system disorder—Temozolomide—brain cancer	0.000788	0.00492	CcSEcCtD
Rifabutin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000777	0.00485	CcSEcCtD
Rifabutin—Skin disorder—Hydroxyurea—brain cancer	0.00077	0.00481	CcSEcCtD
Rifabutin—Jaundice—Etoposide—brain cancer	0.000758	0.00473	CcSEcCtD
Rifabutin—Anorexia—Hydroxyurea—brain cancer	0.000756	0.00472	CcSEcCtD
Rifabutin—Hypersensitivity—Procarbazine—brain cancer	0.000755	0.00472	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000749	0.00511	CbGpPWpGaD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—MYC—brain cancer	0.000749	0.00511	CbGpPWpGaD
Rifabutin—Dysgeusia—Temozolomide—brain cancer	0.000744	0.00464	CcSEcCtD
Rifabutin—Asthenia—Procarbazine—brain cancer	0.000735	0.00459	CcSEcCtD
Rifabutin—Hepatobiliary disease—Etoposide—brain cancer	0.000735	0.00459	CcSEcCtD
Rifabutin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000734	0.00501	CbGpPWpGaD
Rifabutin—Anaemia—Carmustine—brain cancer	0.000726	0.00454	CcSEcCtD
Rifabutin—Agranulocytosis—Etoposide—brain cancer	0.000726	0.00453	CcSEcCtD
Rifabutin—Pruritus—Procarbazine—brain cancer	0.000725	0.00453	CcSEcCtD
Rifabutin—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000724	0.00494	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—PPP1R12A—brain cancer	0.000722	0.00492	CbGpPWpGaD
Rifabutin—Dyspnoea—Hydroxyurea—brain cancer	0.000707	0.00442	CcSEcCtD
Rifabutin—Leukopenia—Carmustine—brain cancer	0.000703	0.00439	CcSEcCtD
Rifabutin—Anaemia—Temozolomide—brain cancer	0.000702	0.00438	CcSEcCtD
Rifabutin—Diarrhoea—Procarbazine—brain cancer	0.000701	0.00438	CcSEcCtD
Rifabutin—Dyspepsia—Hydroxyurea—brain cancer	0.000698	0.00436	CcSEcCtD
Rifabutin—Decreased appetite—Hydroxyurea—brain cancer	0.00069	0.00431	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000685	0.00428	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000684	0.00467	CbGpPWpGaD
Rifabutin—Convulsion—Carmustine—brain cancer	0.000681	0.00425	CcSEcCtD
Rifabutin—Leukopenia—Temozolomide—brain cancer	0.00068	0.00424	CcSEcCtD
Rifabutin—Pain—Hydroxyurea—brain cancer	0.000678	0.00424	CcSEcCtD
Rifabutin—Myalgia—Carmustine—brain cancer	0.000669	0.00418	CcSEcCtD
Rifabutin—Chest pain—Carmustine—brain cancer	0.000669	0.00418	CcSEcCtD
Rifabutin—HSP90AA1—LKB1 signaling events—MYC—brain cancer	0.000664	0.00453	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.00066	0.0045	CbGpPWpGaD
Rifabutin—Convulsion—Temozolomide—brain cancer	0.000658	0.00411	CcSEcCtD
Rifabutin—HSP90AA1—Semaphorin interactions—ERBB2—brain cancer	0.000657	0.00449	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—VAV1—brain cancer	0.000655	0.00447	CbGpPWpGaD
Rifabutin—Feeling abnormal—Hydroxyurea—brain cancer	0.000654	0.00408	CcSEcCtD
Rifabutin—Eye disorder—Etoposide—brain cancer	0.000652	0.00407	CcSEcCtD
Rifabutin—Vomiting—Procarbazine—brain cancer	0.000652	0.00407	CcSEcCtD
Rifabutin—Confusional state—Carmustine—brain cancer	0.000647	0.00404	CcSEcCtD
Rifabutin—Arthralgia—Temozolomide—brain cancer	0.000646	0.00404	CcSEcCtD
Rifabutin—Myalgia—Temozolomide—brain cancer	0.000646	0.00404	CcSEcCtD
Rifabutin—Rash—Procarbazine—brain cancer	0.000646	0.00404	CcSEcCtD
Rifabutin—Dermatitis—Procarbazine—brain cancer	0.000646	0.00403	CcSEcCtD
Rifabutin—Headache—Procarbazine—brain cancer	0.000642	0.00401	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000642	0.00401	CcSEcCtD
Rifabutin—CYP3A4—endocrine gland—brain cancer	0.000636	0.00355	CbGeAlD
Rifabutin—Immune system disorder—Etoposide—brain cancer	0.00063	0.00394	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000629	0.00429	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Carmustine—brain cancer	0.000628	0.00392	CcSEcCtD
Rifabutin—Body temperature increased—Hydroxyurea—brain cancer	0.000627	0.00392	CcSEcCtD
Rifabutin—Confusional state—Temozolomide—brain cancer	0.000625	0.0039	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000616	0.0042	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000616	0.0042	CbGpPWpGaD
Rifabutin—Anorexia—Carmustine—brain cancer	0.000611	0.00382	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—VAV1—brain cancer	0.00061	0.00416	CbGpPWpGaD
Rifabutin—Nausea—Procarbazine—brain cancer	0.000609	0.0038	CcSEcCtD
Rifabutin—Thrombocytopenia—Temozolomide—brain cancer	0.000607	0.00379	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—VAV1—brain cancer	0.000602	0.00411	CbGpPWpGaD
Rifabutin—Skin disorder—Temozolomide—brain cancer	0.000602	0.00376	CcSEcCtD
Rifabutin—Dysgeusia—Etoposide—brain cancer	0.000595	0.00372	CcSEcCtD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000595	0.00406	CbGpPWpGaD
Rifabutin—Anorexia—Temozolomide—brain cancer	0.000591	0.00369	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—IL2—brain cancer	0.000589	0.00402	CbGpPWpGaD
Rifabutin—Hypersensitivity—Hydroxyurea—brain cancer	0.000584	0.00365	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000584	0.00365	CcSEcCtD
Rifabutin—Insomnia—Carmustine—brain cancer	0.00058	0.00362	CcSEcCtD
Rifabutin—Paraesthesia—Carmustine—brain cancer	0.000576	0.0036	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—CCND1—brain cancer	0.000574	0.00392	CbGpPWpGaD
Rifabutin—CYP3A4—central nervous system—brain cancer	0.000573	0.0032	CbGeAlD
Rifabutin—Dyspnoea—Carmustine—brain cancer	0.000572	0.00357	CcSEcCtD
Rifabutin—Asthenia—Hydroxyurea—brain cancer	0.000569	0.00355	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—brain cancer	0.000568	0.00388	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000566	0.00386	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000565	0.00353	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000563	0.00384	CbGpPWpGaD
Rifabutin—Anaemia—Etoposide—brain cancer	0.000562	0.00351	CcSEcCtD
Rifabutin—Insomnia—Temozolomide—brain cancer	0.00056	0.0035	CcSEcCtD
Rifabutin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000559	0.00381	CbGpPWpGaD
Rifabutin—Decreased appetite—Carmustine—brain cancer	0.000557	0.00348	CcSEcCtD
Rifabutin—Paraesthesia—Temozolomide—brain cancer	0.000556	0.00348	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Carmustine—brain cancer	0.000554	0.00346	CcSEcCtD
Rifabutin—Dyspnoea—Temozolomide—brain cancer	0.000552	0.00345	CcSEcCtD
Rifabutin—Pain—Carmustine—brain cancer	0.000548	0.00342	CcSEcCtD
Rifabutin—HSP90AA1—LKB1 signaling events—TP53—brain cancer	0.000546	0.00372	CbGpPWpGaD
Rifabutin—Dyspepsia—Temozolomide—brain cancer	0.000545	0.00341	CcSEcCtD
Rifabutin—Leukopenia—Etoposide—brain cancer	0.000544	0.0034	CcSEcCtD
Rifabutin—Diarrhoea—Hydroxyurea—brain cancer	0.000543	0.00339	CcSEcCtD
Rifabutin—Decreased appetite—Temozolomide—brain cancer	0.000539	0.00336	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—PDGFRA—brain cancer	0.000536	0.00366	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000535	0.00334	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—VEGFA—brain cancer	0.000532	0.00363	CbGpPWpGaD
Rifabutin—Pain—Temozolomide—brain cancer	0.00053	0.00331	CcSEcCtD
Rifabutin—Feeling abnormal—Carmustine—brain cancer	0.000528	0.0033	CcSEcCtD
Rifabutin—Convulsion—Etoposide—brain cancer	0.000526	0.00329	CcSEcCtD
Rifabutin—Gastrointestinal pain—Carmustine—brain cancer	0.000524	0.00327	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CDK6—brain cancer	0.000521	0.00355	CbGpPWpGaD
Rifabutin—Chest pain—Etoposide—brain cancer	0.000517	0.00323	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000514	0.00321	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—RELA—brain cancer	0.000513	0.0035	CbGpPWpGaD
Rifabutin—Feeling abnormal—Temozolomide—brain cancer	0.000511	0.00319	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000507	0.00346	CbGpPWpGaD
Rifabutin—Body temperature increased—Carmustine—brain cancer	0.000507	0.00317	CcSEcCtD
Rifabutin—Abdominal pain—Carmustine—brain cancer	0.000507	0.00317	CcSEcCtD
Rifabutin—Gastrointestinal pain—Temozolomide—brain cancer	0.000507	0.00316	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—TRPC6—brain cancer	0.000504	0.00344	CbGpPWpGaD
Rifabutin—Vomiting—Hydroxyurea—brain cancer	0.000504	0.00315	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—brain cancer	0.0005	0.00341	CbGpPWpGaD
Rifabutin—Rash—Hydroxyurea—brain cancer	0.0005	0.00312	CcSEcCtD
Rifabutin—Confusional state—Etoposide—brain cancer	0.0005	0.00312	CcSEcCtD
Rifabutin—Dermatitis—Hydroxyurea—brain cancer	0.0005	0.00312	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—PDGFRA—brain cancer	0.0005	0.00341	CbGpPWpGaD
Rifabutin—Headache—Hydroxyurea—brain cancer	0.000497	0.0031	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—PDGFRA—brain cancer	0.000493	0.00336	CbGpPWpGaD
Rifabutin—Abdominal pain—Temozolomide—brain cancer	0.00049	0.00306	CcSEcCtD
Rifabutin—Body temperature increased—Temozolomide—brain cancer	0.00049	0.00306	CcSEcCtD
Rifabutin—Thrombocytopenia—Etoposide—brain cancer	0.000486	0.00303	CcSEcCtD
Rifabutin—Skin disorder—Etoposide—brain cancer	0.000482	0.00301	CcSEcCtD
Rifabutin—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000481	0.00328	CbGpPWpGaD
Rifabutin—Anorexia—Etoposide—brain cancer	0.000473	0.00295	CcSEcCtD
Rifabutin—Hypersensitivity—Carmustine—brain cancer	0.000472	0.00295	CcSEcCtD
Rifabutin—Nausea—Hydroxyurea—brain cancer	0.000471	0.00294	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—IRS2—brain cancer	0.000471	0.00321	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—SKP2—brain cancer	0.000466	0.00318	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—IL2—brain cancer	0.000462	0.00315	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—MYC—brain cancer	0.00046	0.00314	CbGpPWpGaD
Rifabutin—Asthenia—Carmustine—brain cancer	0.00046	0.00287	CcSEcCtD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000459	0.00313	CbGpPWpGaD
Rifabutin—Hypersensitivity—Temozolomide—brain cancer	0.000457	0.00285	CcSEcCtD
Rifabutin—HSP90AA1—Disease—DTX2—brain cancer	0.000454	0.0031	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—EGFR—brain cancer	0.00045	0.00307	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000446	0.00305	CbGpPWpGaD
Rifabutin—Paraesthesia—Etoposide—brain cancer	0.000445	0.00278	CcSEcCtD
Rifabutin—Asthenia—Temozolomide—brain cancer	0.000445	0.00278	CcSEcCtD
Rifabutin—Dyspnoea—Etoposide—brain cancer	0.000442	0.00276	CcSEcCtD
Rifabutin—Diarrhoea—Carmustine—brain cancer	0.000439	0.00274	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—IRS2—brain cancer	0.000439	0.00299	CbGpPWpGaD
Rifabutin—Pruritus—Temozolomide—brain cancer	0.000438	0.00274	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IRS2—brain cancer	0.000433	0.00295	CbGpPWpGaD
Rifabutin—Decreased appetite—Etoposide—brain cancer	0.000431	0.00269	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Etoposide—brain cancer	0.000428	0.00267	CcSEcCtD
Rifabutin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000427	0.00291	CbGpPWpGaD
Rifabutin—Pain—Etoposide—brain cancer	0.000424	0.00265	CcSEcCtD
Rifabutin—Diarrhoea—Temozolomide—brain cancer	0.000424	0.00265	CcSEcCtD
Rifabutin—Feeling abnormal—Etoposide—brain cancer	0.000409	0.00255	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—brain cancer	0.000408	0.00279	CbGpPWpGaD
Rifabutin—Vomiting—Carmustine—brain cancer	0.000408	0.00255	CcSEcCtD
Rifabutin—Gastrointestinal pain—Etoposide—brain cancer	0.000405	0.00253	CcSEcCtD
Rifabutin—Rash—Carmustine—brain cancer	0.000404	0.00253	CcSEcCtD
Rifabutin—Dermatitis—Carmustine—brain cancer	0.000404	0.00252	CcSEcCtD
Rifabutin—Headache—Carmustine—brain cancer	0.000402	0.00251	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—SIRT1—brain cancer	0.000397	0.00271	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—CTNNB1—brain cancer	0.000396	0.0027	CbGpPWpGaD
Rifabutin—Vomiting—Temozolomide—brain cancer	0.000394	0.00246	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CCNE1—brain cancer	0.000392	0.00268	CbGpPWpGaD
Rifabutin—Abdominal pain—Etoposide—brain cancer	0.000392	0.00245	CcSEcCtD
Rifabutin—Body temperature increased—Etoposide—brain cancer	0.000392	0.00245	CcSEcCtD
Rifabutin—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000392	0.00267	CbGpPWpGaD
Rifabutin—Rash—Temozolomide—brain cancer	0.000391	0.00244	CcSEcCtD
Rifabutin—Dermatitis—Temozolomide—brain cancer	0.00039	0.00244	CcSEcCtD
Rifabutin—Headache—Temozolomide—brain cancer	0.000388	0.00242	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—VEGFA—brain cancer	0.000386	0.00264	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—SOD2—brain cancer	0.000382	0.00261	CbGpPWpGaD
Rifabutin—Nausea—Carmustine—brain cancer	0.000381	0.00238	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—OR14C36—brain cancer	0.000374	0.00255	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—OR4C12—brain cancer	0.000374	0.00255	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—CTNNB1—brain cancer	0.000373	0.00255	CbGpPWpGaD
Rifabutin—Nausea—Temozolomide—brain cancer	0.000368	0.0023	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—SKP2—brain cancer	0.000366	0.0025	CbGpPWpGaD
Rifabutin—Hypersensitivity—Etoposide—brain cancer	0.000365	0.00228	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—TRPC6—brain cancer	0.00036	0.00246	CbGpPWpGaD
Rifabutin—Asthenia—Etoposide—brain cancer	0.000356	0.00222	CcSEcCtD
Rifabutin—HSP90B1—Immune System—VAV1—brain cancer	0.000355	0.00242	CbGpPWpGaD
Rifabutin—Pruritus—Etoposide—brain cancer	0.000351	0.00219	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—brain cancer	0.000348	0.00238	CbGpPWpGaD
Rifabutin—Diarrhoea—Etoposide—brain cancer	0.000339	0.00212	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.000335	0.00229	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HES5—brain cancer	0.000333	0.00227	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—VEGFA—brain cancer	0.000329	0.00224	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—SKP2—brain cancer	0.000328	0.00224	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDK6—brain cancer	0.000327	0.00223	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000326	0.00222	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.000326	0.00222	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—ERBB2—brain cancer	0.000323	0.0022	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—DTX2—brain cancer	0.000318	0.00217	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000316	0.00216	CbGpPWpGaD
Rifabutin—Vomiting—Etoposide—brain cancer	0.000315	0.00197	CcSEcCtD
Rifabutin—Rash—Etoposide—brain cancer	0.000313	0.00195	CcSEcCtD
Rifabutin—Dermatitis—Etoposide—brain cancer	0.000312	0.00195	CcSEcCtD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000312	0.00213	CbGpPWpGaD
Rifabutin—Headache—Etoposide—brain cancer	0.000311	0.00194	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—RELA—brain cancer	0.000303	0.00207	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—ERBB2—brain cancer	0.000301	0.00205	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CDK4—brain cancer	0.0003	0.00205	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—ERBB2—brain cancer	0.000297	0.00203	CbGpPWpGaD
Rifabutin—Nausea—Etoposide—brain cancer	0.000295	0.00184	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—CDK6—brain cancer	0.000292	0.00199	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PDGFRA—brain cancer	0.000291	0.00199	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CTNNB1—brain cancer	0.000263	0.0018	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP2C9—brain cancer	0.000257	0.00175	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IRS2—brain cancer	0.000255	0.00174	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000246	0.00168	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000244	0.00166	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTCH2—brain cancer	0.000241	0.00164	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.00024	0.00164	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—VAV1—brain cancer	0.000238	0.00163	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HES5—brain cancer	0.000233	0.00159	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—HES1—brain cancer	0.000232	0.00158	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—CTNNB1—brain cancer	0.00023	0.00157	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CDKN2A—brain cancer	0.00023	0.00157	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—BRCA2—brain cancer	0.000227	0.00155	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STRADA—brain cancer	0.000227	0.00155	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IDH1—brain cancer	0.000224	0.00153	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—EGFR—brain cancer	0.000224	0.00153	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—RELA—brain cancer	0.000221	0.00151	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCNE1—brain cancer	0.00022	0.0015	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—BSG—brain cancer	0.000218	0.00149	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—PCNA—brain cancer	0.000218	0.00149	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HEY1—brain cancer	0.000213	0.00145	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—DLL1—brain cancer	0.000209	0.00142	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—EGFR—brain cancer	0.000208	0.00142	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000206	0.0014	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PDGFRA—brain cancer	0.000195	0.00133	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—PCNA—brain cancer	0.000195	0.00133	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ABR—brain cancer	0.000189	0.00129	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDK4—brain cancer	0.000188	0.00129	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000188	0.00128	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—IDH1—brain cancer	0.000188	0.00128	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—ERBB2—brain cancer	0.000186	0.00127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GLI2—brain cancer	0.000183	0.00125	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—SKP2—brain cancer	0.000182	0.00124	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CDK4—brain cancer	0.000182	0.00124	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ENO2—brain cancer	0.000177	0.00121	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SHH—brain cancer	0.000177	0.00121	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—RELA—brain cancer	0.000176	0.0012	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ERBB2—brain cancer	0.000175	0.0012	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GLI1—brain cancer	0.000172	0.00117	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IRS2—brain cancer	0.000171	0.00117	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000169	0.00116	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—brain cancer	0.000169	0.00115	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDK4—brain cancer	0.000168	0.00115	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—STAT3—brain cancer	0.000167	0.00114	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SUFU—brain cancer	0.000163	0.00111	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL2—brain cancer	0.000159	0.00108	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GFAP—brain cancer	0.000157	0.00107	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CTNNB1—brain cancer	0.000153	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HEY1—brain cancer	0.000149	0.00102	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ENO2—brain cancer	0.000148	0.00101	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—DLL1—brain cancer	0.000146	0.000996	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000144	0.000982	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000144	0.000982	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—brain cancer	0.000144	0.000979	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—VAV1—brain cancer	0.000139	0.000947	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—RELA—brain cancer	0.000134	0.000913	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—STAT3—brain cancer	0.000134	0.000912	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—brain cancer	0.000133	0.000907	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000132	0.000903	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000129	0.000884	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000129	0.000884	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—brain cancer	0.000129	0.000881	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—brain cancer	0.000129	0.000878	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—VAV1—brain cancer	0.000128	0.000874	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—brain cancer	0.000128	0.000872	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SHH—brain cancer	0.000124	0.000847	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—brain cancer	0.000122	0.00083	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—brain cancer	0.000121	0.000829	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000121	0.000828	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TRPC6—brain cancer	0.00012	0.000817	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—RELA—brain cancer	0.000118	0.000806	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTCH1—brain cancer	0.000118	0.000803	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SMO—brain cancer	0.000118	0.000803	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—brain cancer	0.000117	0.000801	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CTNNB1—brain cancer	0.000116	0.000794	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PDGFRA—brain cancer	0.000114	0.000775	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HES1—brain cancer	0.00011	0.000752	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—brain cancer	0.000109	0.000742	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PDGFRA—brain cancer	0.000105	0.000716	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CTNNB1—brain cancer	0.000103	0.000701	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—brain cancer	0.000102	0.000699	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—brain cancer	0.000101	0.000692	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IRS2—brain cancer	9.97e-05	0.000681	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—brain cancer	9.76e-05	0.000666	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOTCH2—brain cancer	9.41e-05	0.000642	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—brain cancer	9.22e-05	0.000629	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IRS2—brain cancer	9.21e-05	0.000628	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VAV1—brain cancer	8.97e-05	0.000612	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.87e-05	0.000605	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—brain cancer	8.72e-05	0.000595	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—brain cancer	8.14e-05	0.000555	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APC—brain cancer	8.13e-05	0.000555	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HES1—brain cancer	7.71e-05	0.000526	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDGFRA—brain cancer	7.35e-05	0.000501	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—brain cancer	7.16e-05	0.000489	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SPP1—brain cancer	7.13e-05	0.000487	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RELA—brain cancer	6.88e-05	0.00047	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—brain cancer	6.84e-05	0.000467	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CG—brain cancer	6.81e-05	0.000465	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IRS2—brain cancer	6.45e-05	0.00044	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—brain cancer	6.32e-05	0.000431	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—brain cancer	6.2e-05	0.000423	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTNNB1—brain cancer	5.98e-05	0.000408	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APC—brain cancer	5.7e-05	0.000389	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CG—brain cancer	5.7e-05	0.000389	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—brain cancer	5.53e-05	0.000377	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2C9—brain cancer	5.4e-05	0.000369	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—brain cancer	5.22e-05	0.000356	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—brain cancer	4.82e-05	0.000329	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—brain cancer	4.74e-05	0.000323	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BSG—brain cancer	4.59e-05	0.000313	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—brain cancer	4.48e-05	0.000305	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RELA—brain cancer	4.45e-05	0.000304	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—brain cancer	4.42e-05	0.000302	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—brain cancer	4.38e-05	0.000299	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2C9—brain cancer	4.17e-05	0.000285	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—brain cancer	4.01e-05	0.000273	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—IDH1—brain cancer	3.95e-05	0.00027	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—brain cancer	3.91e-05	0.000267	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—brain cancer	3.87e-05	0.000264	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BSG—brain cancer	3.55e-05	0.000242	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—brain cancer	3.41e-05	0.000232	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—brain cancer	3.37e-05	0.00023	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.22e-05	0.000219	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—brain cancer	3.13e-05	0.000214	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ENO2—brain cancer	3.12e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—brain cancer	3.07e-05	0.000209	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—IDH1—brain cancer	3.05e-05	0.000208	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—brain cancer	2.57e-05	0.000176	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ENO2—brain cancer	2.41e-05	0.000164	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CG—brain cancer	1.43e-05	9.77e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CG—brain cancer	1.11e-05	7.54e-05	CbGpPWpGaD
